IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
B Lymphoblastic Lymphoma
Alliance for Clinical Trials in Oncologymonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
19 Active assets in the B Lymphoblastic Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inotuzumab Ozogamicin Alliance for Clinical Trials in Oncology | Phase 3 | BB |
VINCRISTINE SULFATE Children's Oncology Group | Phase 3 | BB |
Blinatumomab Children's Oncology Group | Phase 3 | BB |
PREDNISONE TABLETS Alliance for Clinical Trials in Oncology | Phase 3 | BB |
MERCAPTOPURINE ANHYDROUS Alliance for Clinical Trials in Oncology | Phase 3 | BB |
View all 22 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →